Frazier Life Sciences Acquisition Corp. II Form 8-K — Oct 15, 2026
Form 8-KItems 1.01, 3.02, 5.03, 8.01, 9.01Filed Oct 15, 2026, 4:23 PM ET0001193125-26-422919Original filing
Frazier Life Sciences Acquisition Corp. II closed its IPO on October 15, 2026, selling 7.5 million Class A ordinary shares at $10.00 per share for gross proceeds of $75 million, with Jefferies LLC as underwriting representative. Concurrently, the sponsor purchased 300,000 private placement shares for $3 million, and Frazier Life Sciences Public Fund, L.P. committed $25 million via a Forward Purchase Agreement to fund the eventual business combination.
Key figures
- Cash Position
- $75,000,000 placed in trust account maintained by Continental Stock Transfer & Trust Company
- Gross Proceeds
- 75000000
- Offering Price
- 10
- Shares Offered
- 7500000
- Trust deadline months
- 24
- Forward purchase shares
- 2500000
- Private placement shares
- 300000
- Underwriter purchase price
- 9.8
- Deferred discount per share
- 0.4
- Forward purchase commitment usd
- 25000000
- Private placement gross proceeds
- 3000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.